» Authors » Amit Akirov

Amit Akirov

Explore the profile of Amit Akirov including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 670
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Rudman Y, Fleseriu M, Dery L, Masri-Iraqi H, Sasson L, Shochat T, et al.
Eur J Endocrinol . 2024 Jul; 191(2):223-231. PMID: 39067000
Objective: Cancer incidence in patients with endogenous Cushing's syndrome (CS) has never been established. Here, we aimed to assess the cancer risk in patients with CS as compared with individually...
12.
Dery L, Stern J, Shimon I, Rudman Y, Kushnir S, Shochat T, et al.
Pituitary . 2024 May; 27(4):389-402. PMID: 38769229
Purpose: The study aimed to characterize the erythrocytic profile in patients with cushing's syndrome (CS) versus controls from the normal population according to etiology, sex, presence of diabetes mellitus (DM)...
13.
Akirov A, Rudman Y, Fleseriu M
Pituitary . 2024 May; 27(6):778-788. PMID: 38709467
Hypopituitarism is a rare but significant endocrine disorder characterized by the inadequate secretion of one or more pituitary hormones. The intricate relationship between hypopituitarism and bone health is a topic...
14.
Ayalon-Dangur I, Rudman Y, Tsvetov G, Slutzky-Shraga I, Akirov A, Shimon I, et al.
Endocrine . 2024 Mar; 85(2):873-882. PMID: 38555314
Purpose: The aims of the current study were to describe clinical and biochemical features of patients with Paget disease of bone (PDB) followed at our medical center, and to examine...
15.
Dotan I, Shochat T, Diker-Cohen T, Akirov A, Gorshtein A
Can J Diabetes . 2024 Mar; 48(5):299-304. PMID: 38508514
Objectives: No data are available regarding glycemic management of individuals with type 1 diabetes (T1D) during Passover. Our aim in this study was to assess the effect of Passover on...
16.
Dotan I, Rudman Y, Turjeman A, Akirov A, Steinmetz T, Calvarysky B, et al.
Transplantation . 2024 Feb; 108(7):e121-e128. PMID: 38361246
Background: Glucagon-like peptide 1 receptor agonists (GLP1-RAs) reduce cardiovascular events and mortality in type 2 diabetes. Limited data are available on diabetes treatment after solid organ transplantation. We aimed to...
17.
Ayalon-Dangur I, Turjeman A, Hirsch D, Robenshtok E, Tsvetov G, Gorshtein A, et al.
Pituitary . 2023 Dec; 27(1):52-60. PMID: 38064148
Purpose: The treatment strategy of non-functioning pituitary adenomas (NFPAs) includes surgery, radiotherapy, medical therapy, or observation without intervention. Cabergoline, a dopaminergic agonist, was suggested for the treatment of NFPA remnants...
18.
Masri-Iraqi H, Rudman Y, Friedrich Dubinchik C, Dotan I, Diker-Cohen T, Sasson L, et al.
Endocr Res . 2023 Jun; 48(2-3):68-76. PMID: 37259228
Limited data are available regarding the association between pre-admission thyroid-stimulating hormone (TSH) levels and prognosis in hospitalized surgical patients treated for hypothyroidism. We retrospectively evaluated a cohort of 1,451 levothyroxine-treated...
19.
Rudman Y, Duskin-Bitan H, Richter I, Tsvetov G, Masri-Iraqi H, Akirov A, et al.
Andrology . 2023 Mar; 11(7):1398-1407. PMID: 36897756
Background: Men harboring prolactinomas frequently suffer from central hypogonadism with secondary anemia. They present insidious and nonspecific symptoms of hypogonadism, making it difficult to diagnose the disease and determine its...
20.
Twito O, Akirov A, Rosenblum R, Herzberg D, Oleinikov K, Rotman-Pikielny P, et al.
Front Endocrinol (Lausanne) . 2023 Feb; 14:1013638. PMID: 36843615
Introduction: Although appendicitis occurs in approximately 1:1000 pregnancies, appendiceal neuroendocrine neoplasm (ANEN) diagnosis during pregnancy is very rare. Data on presentation, treatment and prognosis is scarce. Aim: To describe ANEN...